1221 / 1544
Name I Folie 1 I Datum
Actuarial disease-free survival
for the whole group (a), for patients with low (1)-, intermediate (2)- and high-risk group
(3)(b) and for patients with or without androgen deprivation (c)
a)
b)
c)
Actuarial disease-free survival